DVAX
Dynavax Technologies Corporation
NASDAQ: DVAX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$15.50
+0.00% today
Updated 2026-02-11
Market cap
$1.82B
P/E ratio
—
P/S ratio
5.51x
EPS (TTM)
$-0.37
Dividend yield
—
52W range
$9 – $16
Volume
3.5M
Dynavax Technologies Corporation (DVAX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-0.13%
Operating margin
0.25%
ROE
-0.07%
ROA
0.01%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2005 | $14.65M | $-20.55M | 100.00% | -153.46% | -140.26% |
| 2006 | $4.85M | $-52.05M | 85.60% | -1,340.68% | -1,073.90% |
| 2007 | $14.09M | $-59.97M | 92.88% | -504.45% | -425.54% |
| 2008 | $37.09M | $-20.83M | 97.36% | -65.02% | -56.15% |
| 2009 | $40.32M | $-30.57M | 97.57% | -37.49% | -75.81% |
| 2010 | $23.95M | $-57.31M | 95.91% | -198.70% | -239.28% |
| 2011 | $21.61M | $-48.60M | 98.62% | -220.12% | -224.84% |
| 2012 | $9.71M | $-69.95M | 100.00% | -695.86% | -720.08% |
| 2013 | $11.25M | $-66.72M | 100.00% | -590.95% | -593.01% |
| 2014 | $11.03M | $-90.72M | 100.00% | -827.69% | -822.35% |
| 2015 | $4.05M | $-106.79M | 100.00% | -2,594.40% | -2,636.89% |
| 2016 | $11.04M | $-112.44M | 100.00% | -1,002.51% | -1,018.24% |
| 2017 | $327000.00 | $-95.15M | -265.14% | -29,359.33% | -29,099.08% |
| 2018 | $8.20M | $-158.90M | -165.87% | -1,870.20% | -1,938.27% |
| 2019 | $35.22M | $-152.60M | 44.95% | -382.87% | -433.29% |
| 2020 | $46.55M | $-75.24M | 70.12% | -161.59% | -161.63% |
| 2021 | $439.44M | $76.71M | 60.50% | 30.60% | 17.46% |
| 2022 | $722.68M | $293.16M | 63.73% | 39.23% | 40.56% |
| 2023 | $232.28M | $-6.39M | 78.40% | -15.94% | -2.75% |
| 2024 | $277.25M | $27.31M | 82.17% | -1.49% | 9.85% |